ArticleBiochemistry and biophysics reports2022

Synergistic inhibition of hepatitis C virus infection by a novel microtubule inhibitor in combination with daclatasvir.

Huijun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.